267 - Sedative Use in Infants with Grade 3 Bronchopulmonary Dysplasia (BPD) and Associations with Neurodevelopmental Therapies

Thomas Davis, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Divya Rana, UTHSC, Memphis, TN, United States; Audrey Miller, Nationwide childrens hospital, Columbus, OH, United States; Meaghan Ransom, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, United States; Bridget DiPrisco, Keck School of Medicine of the University of Southern California, Santa Monica, CA, United States; Karishma Rao, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Tara L. DuPont, University of Utah, Salt Lake City, UT, United States; Melissa Hanin, Nationwide Children's Hospital, Bexley, OH, United States; Melissa House, Emory University School of Medicine, Atlanta, GA, United States; Brianna K.. Brei, University of Nebraska College of Medicine, Omaha, NE, United States; Susan Gage, CHOC Children's Hospital of Orange County, Orange, CA, United States; Matthew Coyle, Childrens Hospital of Philadelphia, Springfield, PA, United States; Sara B.. DeMauro, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States